3.19
전일 마감가:
$3.10
열려 있는:
$3.1
하루 거래량:
94,886
Relative Volume:
1.91
시가총액:
$83.21M
수익:
$6.21M
순이익/손실:
$-19.92M
주가수익비율:
-3.0381
EPS:
-1.05
순현금흐름:
$-16.76M
1주 성능:
+8.14%
1개월 성능:
+8.50%
6개월 성능:
+11.93%
1년 성능:
+22.48%
InspireMD Inc. Stock (NSPR) Company Profile
명칭
InspireMD Inc.
전화
972 3 6917691
주소
4 Menorat Hamaor Street, Tel Aviv
NSPR을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
NSPR
InspireMD Inc.
|
3.19 | 83.21M | 6.21M | -19.92M | -16.76M | -1.05 |
![]()
ABT
Abbott Laboratories
|
134.92 | 234.01B | 41.95B | 13.40B | 6.49B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
104.49 | 154.20B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
382.78 | 146.06B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
89.94 | 115.42B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
73.30 | 43.23B | 5.72B | 4.17B | 490.10M | 6.97 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2016-01-07 | 개시 | Rodman & Renshaw | Buy |
2015-03-13 | 다운그레이드 | Oppenheimer | Outperform → Perform |
2013-11-26 | 개시 | Oppenheimer | Outperform |
InspireMD Inc. 주식(NSPR)의 최신 뉴스
InspireMD and NAMSA to begin study of carotid stent system for TCAR procedures - Yahoo
InspireMD (NYSE:NSPR) Coverage Initiated at StockNews.com - Defense World
InspireMD and NAMSA to Partner on CGUARDIANS II Pivotal - GlobeNewswire
InspireMD And NAMSA To Partner On CGuardians II Pivotal Clinical Trial Of The CGuard Prime 80 Cm Carotid Stent System For Use In TCAR Procedures - Marketscreener.com
Major Clinical Trial Alert: InspireMD's Revolutionary TCAR Stent Targets $1B+ Market - StockTitan
StockNews.com Begins Coverage on InspireMD (NYSE:NSPR) - Defense World
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Key Executive Compensation Alert: InspireMD Awards Strategic Stock Package to New Hire - StockTitan
InspireMD (NYSE:NSPR) Now Covered by Analysts at StockNews.com - Defense World
Investors in InspireMD (NASDAQ:NSPR) from five years ago are still down 86%, even after 10% gain this past week - Simply Wall St
Compliance Issues And Stock Developments Hit Nasdaq Companies - Evrim Ağacı
InspireMD Awards Strategic Employee Stock Grants to Accelerate Growth, Adds 9 New Hires - StockTitan
StockNews.com Initiates Coverage on InspireMD (NYSE:NSPR) - Defense World
InspireMD : Breakthrough device in clinical trials aims to prevent strokes -January 20, 2025 at 07:59 am EST - Marketscreener.com
Here's Why We're Watching InspireMD's (NASDAQ:NSPR) Cash Burn Situation - Yahoo Finance
InspireMD (NYSE:NSPR) Coverage Initiated by Analysts at StockNews.com - MarketBeat
InspireMD (NYSE:NSPR) Now Covered by StockNews.com - Defense World
InspireMD (NYSE:NSPR) Earns Sell Rating from Analysts at StockNews.com - MarketBeat
InspireMD, Inc. CFO Craig Shore to Retire, Company Initiates Search for SuccessorDecember 12, 2024 - Defense World
NSPRInspireMD, Inc. Latest Stock News & Market Updates - StockTitan
Medical device company kicks off search for next CFO - The Business Journals
InspireMD CFO Craig Shore to retire, successor search underway - Investing.com India
InspireMD CFO Retirement Amid Strategic Transition - TipRanks
InspireMD Announces Expected Retirement of its CFO Craig Shore and CFO Transition in 2025 - GlobeNewswire
InspireMD CFO to Retire After 15 Years Amid Crucial FDA Approval Timeline for Stroke Prevention Device - StockTitan
NSPR Stock May Gain as First Patient Enrolls in CGUARDIANS II Study - MSN
Lake Street Initiates Coverage of InspireMD (NSPR) with Buy Recommendation - MSN
InspireMD Announces First Patient Enrolled in CGUARDIANS II Pivotal Study - Defense World
Inspiremd Announces First Patient Enrolled in the Cguardians Ii Pivotal Study of the Cguard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures - Marketscreener.com
InspireMD Advances CGuard Prime with New Clinical Trial - TipRanks
InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures (TCAR) - GlobeNewswire
InspireMD Launches Pivotal CGUARDIANS II Trial for Revolutionary Carotid Stent System - StockTitan
Head to Head Contrast: Penumbra (NYSE:PEN) vs. InspireMD (NYSE:NSPR) - Defense World
InspireMD adds medtech veteran Scott Ward to its board By Investing.com - Investing.com South Africa
InspireMD appoints Scott R. Ward to its Board - Medical Buyer
InspireMD Appoints Scott R. Ward to Board of Directors - Defense World
InspireMD, Inc. Appoints Scott R. Ward to Its Board of Directors - Marketscreener.com
InspireMD adds medtech veteran Scott Ward to its board - Investing.com
InspireMD Strengthens Leadership with Scott R. Ward Appointment - TipRanks
InspireMD Announces Appointment of Accomplished Medical - GlobeNewswire
InspireMD Strengthens Board with Ex-Medtronic Executive Ahead of CGuard Prime FDA Decision | NSPR Stock News - StockTitan
InspireMD Inc. (NSPR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):